Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?

Published:2015-11-13 Issue:1 Volume:10 Page:29-38
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

De Ferrari Laura,Chiappori Alessandra,Bagnasco Diego,Riccio Anna Maria,Passalacqua Giovanni,Canonica Giorgio Walter

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1586/17476348.2016.1111763

Reference103 articles.

1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

2. Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma

3. The Path to Personalized Medicine

4. Severe asthma: from characteristics to phenotypes to endotypes

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness analysis of dupilumab versus omalizumab, mepolizumab, and benralizumab added to the standard of care in adults with severe asthma in Colombia;Expert Review of Pharmacoeconomics & Outcomes Research;2023-11-23

2. MicroRNA-21 promotes epithelial-mesenchymal transition and migration of human bronchial epithelial cells by targeting poly (ADP-ribose) polymerase-1 and activating PI3K/AKT signaling;The Korean Journal of Physiology & Pharmacology;2022-07-01

3. Multi-Omics Profiling Approach to Asthma: An Evolving Paradigm;Journal of Personalized Medicine;2022-01-07

4. Biological therapies targeting the type 2 inflammatory pathway in severe asthma (Review);Experimental and Therapeutic Medicine;2021-09-06

5. Evaluation of serum levels of interleukin-10 and transforming growth factor-β1 among Egyptian children with wheezy asthma phenotype;The Egyptian Journal of Chest Diseases and Tuberculosis;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3